Horizon 2020, Health, demographic change and well-being. Call 2018: Better Health and care, economic growth and sustainable health systems.
- Entitat convocant:
- European Commission
- Categoria:
- Projectes de recerca
- Àmbit:
- Internacional
- Inici:
- Termini intern:
- Termini real:
- Descripció:
-
Objectiu de la convocatòria
Horizon 2020 is the EU funding programme for research and innovation running from 2014 to 2020. The Horizon 2020 societal challenge of 'health, demographic change and wellbeing' (SC1) for the years 2018-2020 is strategically orientated to 'Better health and care, economic growth and sustainable health systems".
This call of Horizon 2020 aims at reconciling better health and healthy ageing with the need to develop sustainable health and care systems and growth opportunities for the health and care related industries. The scope of the call may range from prevention, diagnosis, stratified approaches, predictive toxicology, the development of novel and repurposed therapeutic approaches, including medical technologies and advanced therapies, cohorts and registries-based research, to integration of care and systemic digital solutions for health and ageing well. The topics mentioned below fund Research and Innovation Actions (RIA).
Característiques principals
Topics:
Deadline 18 April 2018- SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease
- SC1-BHC-04-2018: Rare Disease European Joint Programme Cofund
- SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches
- SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future
- SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
- SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
- SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation
- SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
- SC1-BHC-26-2018: HTA research to support evidence-based healthcare
- SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals
- SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
- SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine - a European standardization framework
- SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
- SC1-HCO-05-2018: Strengthening regulatory sciences and supporting regulatory scientific advice
- SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats
- SC1-HCO-08-2018: Creation of a European wide sustainable clinical research network for infectious diseases
- SC1-HCO-09-2018: Building international efforts on population and patient cohorts
- SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives
- SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China
- SC1-HCO-12-2018: Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
- SC1-HCO-13-2018: Setting the priorities for a European environment, climate and health research agenda
- Deadline 06 February 2018 (2-stage call)
- SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
Convocatòria (URL)
- SC1-BHC-03-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-03-2018.html<
- SC1-BHC-04-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-04-2018.html<
- SC1-BHC-05 2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-05-2018.html<
- SC1-BHC-09-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-09-2018.html<
- SC1-BHC-16-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-16-2018.html<
- SC1-BHC-18-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-18-2018.html<
- SC1-BHC-21-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-21-2018.html<
- SC1-BHC-23-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-23-2018.html<
- SC1-BHC-26-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-26-2018.html<
- SC1-BHC-27-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-27-2018.html<
- SC1-HCO-01-2018-2019-2020: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-01-2018-2019-2020.html<
- SC1-HCO-02-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-02-2018.html<
- SC1-HCO-04-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-04-2018.html<
- SC1-HCO-05-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-05-2018.html<
- SC1-HCO-06-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-06-2018.html<
- SC1-HCO-08-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-08-2018.html<
- SC1-HCO-09-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-09-2018.html<
- SC1-HCO-10-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-10-2018.html<
- SC1-HCO-11-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-11-2018.html<
- SC1-HCO-12-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-12-2018.html<
- SC1-HCO-13-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-13-2018.html<
- Deadline 06 February 2018 (2-stage call)
- SC1-BHC-15-2018: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-15-2018.html
Requisits
Eligibility:
- Entities established in the Member States of the European Unión. Entities from other countries may be also eligible for funding.
- A project must involve at least three legal entities established in 3 EU Member States or countries associated to Horizon 2020 with the following exception:
- - Topic SC1-BHC-05-2018: the proposals must include additionally at least one participant from Canada.
- - Topic SC1-BHC-18-2018: the proposals must include additionally at least two participants from two different CELAC countries.
- - Topic SC1-BHC-21-2018: the proposals must include additionally at least one participant from the Russian FederationPlease see annex A of the Work Programme.
Funding
The grant covers 100% of projects’ costs.
AVÍS IMPORTANT
The topic SC1-BHC-15-2018, New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID), is financed through the new Lump Sum Pilot instrument, which introduces important changes in the way the project is funded and paid. In case you intend to submit a proposal to this topic, please contact the Servei de Recerca as soon as possible.